| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |